Cognition Therapeutics, Inc.CGTXNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank60
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
-6.39%
↑ 72% vs avg
Percentile
P60
Within normal range
Streak
3 yr
Consecutive growthAccelerating
Average
-22.84%
Historical baseline
PeriodValue
2024-6.39%
2023-16.47%
2022-52.29%
2021-64.29%
20202.38%
20190.00%